{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T21:31:54Z","timestamp":1782768714677,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.imlet.2022.06.009","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T21:10:06Z","timestamp":1655932206000},"page":"70-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Benralizumab reduces eosinophils and inflammatory markers in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: A pilot real-life study."],"prefix":"10.1016","volume":"248","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0378-8935","authenticated-orcid":false,"given":"Carlo","family":"Cavaliere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Segatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ciofalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0639-806X","authenticated-orcid":false,"given":"Andrea","family":"Colizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Minni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Messineo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8974-991X","authenticated-orcid":false,"given":"Alessandro","family":"Lambiase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"de Vincentiis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Masieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.imlet.2022.06.009_bib0001","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1398-9995.2011.02646.x","article-title":"Chronic rhinosinusitis in Europe\u2013an underestimated disease. A GA\u00b2LEN study","volume":"66","author":"Hastan","year":"2011","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.imlet.2022.06.009_bib0002","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","article-title":"Chronic rhinosinusitis with nasal polyps","volume":"4","author":"Stevens","year":"2016","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.imlet.2022.06.009_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhin20.401","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.imlet.2022.06.009_bib0004","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/JAA.S290424","article-title":"Burden of disease in chronic rhinosinusitis with nasal polyps","volume":"14","author":"Bachert","year":"2021","journal-title":"J. Asthma Allergy"},{"issue":"12","key":"10.1016\/j.imlet.2022.06.009_bib0005","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/17476348.2020.1812388","article-title":"An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma","volume":"14","author":"Castagnoli","year":"2020","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.imlet.2022.06.009_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105947","article-title":"Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: evidences from the severe asthma network Italy (SANI) registry","volume":"166","author":"Canonica","year":"2020","journal-title":"Respir. Med."},{"key":"10.1016\/j.imlet.2022.06.009_bib0007","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000128659","article-title":"Asthma and sinusitis: association and implication","volume":"147","author":"Matsuno","year":"2008","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.imlet.2022.06.009_bib0008","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4193\/Rhino09.095","article-title":"Comparative clinical and airway inflammatory features of asthma with or without nasal polyposis","volume":"48","author":"Bilodeau","year":"2010","journal-title":"Rhinology"},{"key":"10.1016\/j.imlet.2022.06.009_bib0009","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1155\/2018\/9095275","article-title":"\"Eosinophils from physiology to disease: a comprehensive review","volume":"2018","author":"Ramirez","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.imlet.2022.06.009_bib0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MCP.0000000000000741","article-title":"Managing chronic rhinosinusitis in severe asthma","volume":"27","author":"Ramaswamy","year":"2021","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"12","key":"10.1016\/j.imlet.2022.06.009_bib0011","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/17476348.2020.1812388","article-title":"An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma","volume":"14","author":"Castagnoli","year":"2020","journal-title":"Expert Rev. Respir. Med."},{"issue":"1","key":"10.1016\/j.imlet.2022.06.009_bib0012","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4168\/aair.2021.13.1.8","article-title":"Biology and function of eosinophils in chronic rhinosinusitis with or without nasal polyps","volume":"13","author":"Bochner","year":"2021","journal-title":"Allergy Asthma Immunol. Res."},{"key":"10.1016\/j.imlet.2022.06.009_bib0013","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/alr.22214","article-title":"Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement","volume":"8","author":"Lou","year":"2018","journal-title":"Int. Forum Allergy Rhinol."},{"key":"10.1016\/j.imlet.2022.06.009_bib0014","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1080\/1744666X.2018.1512407","article-title":"Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps","volume":"14","author":"Heffler","year":"2018","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.imlet.2022.06.009_bib0015","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1146\/annurev-immunol-093019-125918","article-title":"Eosinophil knockout humans: uncovering the role of eosinophils through eosinophil-directed biological therapies","volume":"39","author":"Jacobsen","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imlet.2022.06.009_bib0016","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00405-002-0467-9","article-title":"Immunohistochemical expression of VEGF and VEGF receptors in nasal polyps as compared to normal turbinate mucosa","volume":"259","author":"Wittekindt","year":"2002","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"3","key":"10.1016\/j.imlet.2022.06.009_bib0017","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jaci.2005.06.007","article-title":"Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases","volume":"116","author":"Puxeddu","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2022.06.009_bib0018","unstructured":"Difficult-to-treat and severe asthma guide 2019. 2019. At https:\/\/ginasthma.org\/severeasthma\/."},{"key":"10.1016\/j.imlet.2022.06.009_bib0019","doi-asserted-by":"crossref","unstructured":"Development of the asthma control test: a survey for assessing asthma control by Nathan et\u00a0al. in American academy of allergy, Asthma and Immunol.doi:10.1016\/j.jaci.2003.09.008.","DOI":"10.1016\/j.jaci.2003.09.008"},{"key":"10.1016\/j.imlet.2022.06.009_bib0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s40629-016-0006-7","article-title":"Visual analogue scales (VAS): measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care","volume":"26","author":"Klimek","year":"2017","journal-title":"Allergo J. Int."},{"key":"10.1016\/j.imlet.2022.06.009_bib0021","series-title":"Sino-Nasal Outcome Test (SNOT-22)","year":"2006"},{"issue":"1","key":"10.1016\/j.imlet.2022.06.009_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-7022-1-2","article-title":"Diagnostic tools in rhinology EEACI position paper","volume":"1","author":"Scadding","year":"2011","journal-title":"Clin. Transl. Allergy"},{"key":"10.1016\/j.imlet.2022.06.009_bib0023","unstructured":"Lund V.J., Mackay I.S. Staging in rhinosinusitus. Rhinology. 31 (4): 183\u20134."},{"key":"10.1016\/j.imlet.2022.06.009_bib0024","first-page":"37","volume":"32","author":"Gelardi","year":"2018","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.imlet.2022.06.009_bib0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"issue":"10056","key":"10.1016\/j.imlet.2022.06.009_bib0026","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"CALIMA study investigators. Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as addon treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"issue":"10056","key":"10.1016\/j.imlet.2022.06.009_bib0027","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"SIROCCO study investigators. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.imlet.2022.06.009_bib0028","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S2213-2600(20)30414-8","volume":"9","author":"Harrison","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.imlet.2022.06.009_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106080","article-title":"Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis","volume":"171","author":"Bagnasco","year":"2020","journal-title":"Respir. Med."},{"key":"10.1016\/j.imlet.2022.06.009_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2020.101966","article-title":"Significant improvement in lung function and asthma control after benralizumab treatment for severe refractory eosinophilic asthma","volume":"64","author":"Menzella","year":"2020","journal-title":"Pulm Pharmacol. Ther."},{"key":"10.1016\/j.imlet.2022.06.009_bib0031","doi-asserted-by":"crossref","DOI":"10.1177\/2058738420950851","article-title":"Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma","volume":"34","author":"Lombardo","year":"2020","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.imlet.2022.06.009_bib0032","doi-asserted-by":"crossref","unstructured":"Licari A., Castagnoli R., Denicol\u00f2 C.F., Rossini L., Marseglia A., Marseglia G.L. The nose and the lung: united airway disease? Front pediatr. 2017 Mar 3;5:44. doi: 10.3389\/fped.2017.00044. PMID: 28316969; PMCID: PMC5334318.","DOI":"10.3389\/fped.2017.00044"},{"key":"10.1016\/j.imlet.2022.06.009_bib0033","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1513\/pats.200906-052DP","article-title":"United airways concept: what does it teach us about systemic inflammation in airways disease?","volume":"6","author":"Braunstahl","year":"2009","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.imlet.2022.06.009_bib0034","doi-asserted-by":"crossref","unstructured":"Likness M.M., Pallanch J.F., Sherris D.A., Kita H., Mashtare T.L. Jr, Ponikau J.U. Computed tomography scans as an objective measure of disease severity in chronic rhinosinusitis. Otolaryngol. Head Neck Surg. 2014 Feb;150(2):305\u201311. doi: 10.1177\/0194599813513881. Epub 2013 Dec 3. PMID: 24301090; PMCID: PMC3986264.","DOI":"10.1177\/0194599813513881"},{"key":"10.1016\/j.imlet.2022.06.009_bib0035","unstructured":"ClinicalTrials.gov identifier: NCT00512486."},{"key":"10.1016\/j.imlet.2022.06.009_bib0036","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.rmed.2016.01.003","article-title":"Reductions in eosinophil biomarkers by benralizumab in patients with asthma","volume":"111","author":"Pham","year":"2016","journal-title":"Respir. Med."},{"issue":"6","key":"10.1016\/j.imlet.2022.06.009_bib0037","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2010.04.004","article-title":"MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function","volume":"125","author":"Kolbeck","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2022.06.009_bib0038","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma\u2013present in most, absent in many","volume":"15","author":"Fahy","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2022.06.009_bib0039","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2022.06.009_bib0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1164\/rccm.202003-0634ED","article-title":"Asthma and the dysregulated immune response to rhinovirus","volume":"202","author":"Wark","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.imlet.2022.06.009_bib0041","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02422-2018","article-title":"Aberrant anti-viral response of natural killer cells in severe asthma","volume":"55","author":"Devulder","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.imlet.2022.06.009_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106501","article-title":"Asthma is associated with multiple alterations in anti-viral innate signalling pathways","volume":"9","author":"Pritchard","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imlet.2022.06.009_bib0043","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/nm1105","article-title":"Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung","volume":"10","author":"Lee","year":"2004","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.imlet.2022.06.009_bib0044","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000235998","article-title":"Mast cells and basophils: a potential link in promoting angiogenesis during allergic inflammation","volume":"151","author":"Crivellato","year":"2009","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2022.06.009_bib0045","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaci.2013.05.020","article-title":"Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia","volume":"132","author":"Laviolette","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2022.06.009_bib0046","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.anai.2021.01.010","article-title":"Nasal expression of the vascular endothelial growth factor and its receptors is reduced by mepolizumab in chronic rhinosinusitis with nasal polyposis","volume":"126","author":"Cavaliere","year":"2021","journal-title":"Ann. Allergy Asthma Immunol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247822000967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247822000967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:41:42Z","timestamp":1759045302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247822000967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":46,"alternative-id":["S0165247822000967"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2022.06.009","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benralizumab reduces eosinophils and inflammatory markers in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: A pilot real-life study.","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2022.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}]}}